Gaucher Disease

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

Sanofi plans regulatory discussions on the Gaucher data with fuller results to be presented at an upcoming medical meeting.